MaxCyte Inc on Tuesday said it appointed Douglas Swirsky as its new chief financial officer, effective immediately.
The Maryland, US-based cell-engineering focused company said Swirsky previously. | March 28, 2023
ROCKVILLE, Md., March 27, 2023 MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization. | March 27, 2023
/PRNewswire/ The "Global Targeted Drug Delivery Market by Disease Type, Application, End-user, and Region - Size, Share, Outlook, and Opportunity Analysis,.